Aim

The International Journal of Molecular Medicine and Advance Sciences (IJMMAS) is an international, peer-reviewed, open access scholarly journal dedicated to publishing high-quality, original, and innovative research in the fields of molecular medicine, biomedical sciences, and advanced life sciences. The journal aims to advance scientific knowledge by providing a platform for researchers, clinicians, academicians, and healthcare professionals to disseminate significant discoveries that contribute to the understanding, prevention, diagnosis, and treatment of human diseases.

IJMMAS promotes interdisciplinary research that bridges basic science, translational research, and clinical practice. The journal is committed to publishing scientifically rigorous, ethically conducted, and impactful research that supports evidence-based medicine and fosters global collaboration in healthcare and biomedical innovation.

Scope

The journal welcomes original research articles, review articles, systematic reviews, meta-analyses, short communications, case reports, technical notes, editorials, perspectives, and letters to the editor in, but not limited to, the following areas:

• Molecular Medicine
• Molecular Biology
• Medical Genetics and Genomics
• Proteomics and Metabolomics
• Cell Biology
• Stem Cell Biology and Regenerative Medicine
• Cancer Biology and Oncology
• Precision Medicine and Personalized Medicine
• Clinical and Translational Medicine
• Immunology and Immunotherapy
• Microbiology and Medical Microbiology
• Virology
• Infectious Diseases
• Pharmacology and Clinical Pharmacology
• Toxicology
• Clinical Biochemistry
• Biotechnology and Biomedical Engineering
• Bioinformatics and Computational Biology
• Neuroscience
• Cardiovascular Medicine
• Endocrinology and Metabolism
• Gastroenterology and Hepatology
• Nephrology
• Pulmonology and Respiratory Medicine
• Rheumatology
• Dermatology
• Hematology
• Reproductive Medicine
• Obstetrics and Gynecology
• Pediatrics
• Geriatric Medicine
• Public Health and Epidemiology
• Environmental and Occupational Health
• Nanomedicine
• Drug Discovery and Drug Delivery Systems
• Biomarkers and Diagnostic Technologies
• Gene Therapy
• RNA Biology
• Clinical Laboratory Sciences
• Artificial Intelligence Applications in Healthcare
• Digital Health and Medical Informatics
• One Health and Emerging Infectious Diseases
• Any other emerging areas related to molecular medicine, biomedical sciences, and advanced medical research.

IJMMAS encourages interdisciplinary and collaborative research that integrates biological, clinical, pharmaceutical, technological, and computational sciences to address current and future challenges in medicine and healthcare. The journal welcomes submissions from researchers, clinicians, healthcare professionals, academic institutions, research organizations, and industry worldwide that demonstrate scientific excellence, methodological rigor, ethical compliance, and significant contributions to the advancement of molecular medicine and related disciplines.